Larynx Squamous Cell Carcinoma
6 clinical trials · Condition
◉ Watch Larynx Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients (NCT04858269) | Wake Forest University Health Sciences | 2021-05-27 |
| Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. (NCT04445064) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2020-08-14 |
| IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma (NCT03381183) | H. Lee Moffitt Cancer Center and Research Institute | 2019-08-21 |
Track Larynx Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.